科济药业-B12月16日斥资1476.2万港元回购101万股

Core Viewpoint - Company Kojis Pharmaceuticals (02171) announced a share buyback plan, intending to repurchase 1.01 million shares for a total cost of HKD 14.762 million, scheduled for December 16, 2025 [1] Group 1 - The total amount allocated for the share buyback is HKD 14.762 million [1] - The number of shares to be repurchased is 1.01 million [1] - The buyback is set to occur on December 16, 2025 [1]